Paul B. Robbins
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Renal cell carcinoma treatment
Papers in
- Oncology 23
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 5
-
- Renal cell carcinoma treatment 9
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Paul A. Khavari (6 shared papers)Donald B. Kohn (4 shared papers)Qun Lin (3 shared papers)Stephanie Halene (2 shared papers)Kathleen A. Clouse (2 shared papers)Xiaojin Yu (2 shared papers)Jim P. Doherty (2 shared papers)Yakov Chudnovsky (1 shared paper)
- Journals
- Annals of Oncology (11 papers)European Journal of Cancer (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)Diagnostic Pathology (3 papers)Human Gene Therapy (3 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Paul B. Robbins
52 papers receiving 5.1k citations
Paul B. Robbins's Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 1.9k
- Virology 245
- Cancer Research 716
- Immunology 792
Countries citing papers authored by Paul B. Robbins
This map shows the geographic impact of Paul B. Robbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul B. Robbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul B. Robbins more than expected).
Fields of papers citing papers by Paul B. Robbins
This network shows the impact of papers produced by Paul B. Robbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul B. Robbins. The network helps show where Paul B. Robbins may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul B. Robbins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma Hit paper breakdown → | 2019 | 1971 |
| 2 | Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial Hit paper breakdown → | 2020 | 372 |
| 3 | 2018 | 222 | |
| 4 | 2016 | 169 | |
| 5 | 2018 | 164 | |
| 6 | 1989 | 163 | |
| 7 | 2005 | 160 | |
| 8 | 1991 | 159 | |
| 9 | 2016 | 158 | |
| 10 | 1999 | 132 | |
| 11 | 1998 | 122 | |
| 12 | 1997 | 111 | |
| 13 | 2022 | 111 | |
| 14 | 2001 | 103 | |
| 15 | 2016 | 101 | |
| 16 | 1989 | 85 | |
| 17 | 2021 | 81 | |
| 18 | 2019 | 74 | |
| 19 | 2021 | 70 | |
| 20 | 2017 | 57 |
About Paul B. Robbins
Paul B. Robbins is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Virology and Molecular Biology, having authored 54 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Renal cell carcinoma treatment (9 papers), Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (7 papers), Virus-based gene therapy research (6 papers), CRISPR and Genetic Engineering (5 papers), CAR-T cell therapy research (5 papers) and HIV Research and Treatment (5 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (1.9k citations), Virology (245 citations), Cancer Research (716 citations) and Immunology (792 citations). Paul B. Robbins has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Paul A. Khavari, Donald B. Kohn, Qun Lin, Stephanie Halene, Kathleen A. Clouse, Xiaojin Yu, Jim P. Doherty, Yakov Chudnovsky, Amy E. Adams and Anna A. Kuang. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal for ImmunoTherapy of Cancer, Diagnostic Pathology and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.